121 related articles for article (PubMed ID: 38105473)
21. Preoperative C-reactive protein/albumin ratio to predict mortality and recurrence of patients with hepatocellular carcinoma after curative resection.
Ren Y; Fan X; Chen G; Zhou D; Lin H; Cai X
Med Clin (Barc); 2019 Sep; 153(5):183-190. PubMed ID: 30606506
[TBL] [Abstract][Full Text] [Related]
22. Novel Prognostic Nomograms Based on Inflammation-Related Markers for Patients with Hepatocellular Carcinoma Underwent Hepatectomy.
Wang Y; Sun K; Shen J; Li B; Kuang M; Cao Q; Peng S
Cancer Res Treat; 2019 Oct; 51(4):1464-1478. PubMed ID: 30913869
[TBL] [Abstract][Full Text] [Related]
23. MR elastography as a biomarker for prediction of early and late recurrence in HBV-related hepatocellular carcinoma patients before hepatectomy.
Zhang L; Chen J; Jiang H; Rong D; Guo N; Yang H; Zhu J; Hu B; He B; Yin M; Venkatesh SK; Ehman RL; Wang J
Eur J Radiol; 2022 Jul; 152():110340. PubMed ID: 35580445
[TBL] [Abstract][Full Text] [Related]
24. Inflammatory indexes in preoperative blood routine to predict early recurrence of hepatocellular carcinoma after curative hepatectomy.
Wu Y; Tu C; Shao C
BMC Surg; 2021 Apr; 21(1):178. PubMed ID: 33794850
[TBL] [Abstract][Full Text] [Related]
25. Prognostic Value of Pre-Operative Platelet to Lymphocyte Ratio in Patients with Resected Primary Hepatocellular Carcinoma.
Dong L; Bai K; Cao Y; Huang Q; Lv L; Jiang Y
Clin Lab; 2016 Nov; 62(11):2191-2196. PubMed ID: 28164677
[TBL] [Abstract][Full Text] [Related]
26. Changes in Inflammatory Markers Predict the Prognosis of Resected Hepatocellular Carcinoma with Child-Pugh A.
Zhou J; Yang D
Curr Oncol; 2022 Aug; 29(8):5800-5809. PubMed ID: 36005195
[TBL] [Abstract][Full Text] [Related]
27. The Severity of Liver Fibrosis Influences the Prognostic Value of Inflammation-Based Scores in Hepatitis B-Associated Hepatocellular Carcinoma.
Wang Q; Blank S; Fiel MI; Kadri H; Luan W; Warren L; Zhu A; Deaderick PA; Sarpel U; Labow DM; Hiotis SP
Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1125-32. PubMed ID: 26159441
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of platelet distribution width to lymphocyte ratio in patients with hepatocellular carcinoma following hepatectomy.
Zhong ZH; Liang L; Fu TW; Dai MG; Cheng J; Liu SY; Ye TW; Shen GL; Zhang CW; Huang DS; Liu JW
BMC Cancer; 2023 Nov; 23(1):1116. PubMed ID: 37974129
[TBL] [Abstract][Full Text] [Related]
29. Lymphocyte to monocyte ratio and neutrophil to lymphocyte ratio are superior inflammation-based predictors of recurrence in patients with hepatocellular carcinoma after hepatic resection.
Yang T; Zhu J; Zhao L; Mai K; Ye J; Huang S; Zhao Y
J Surg Oncol; 2017 May; 115(6):718-728. PubMed ID: 28127774
[TBL] [Abstract][Full Text] [Related]
30. AGLR is a novel index for the prognosis of hepatocellular carcinoma patients: a retrospective study.
Liao Y; Wei R; Yao R; Qin L; Li J; Yu J; Liao W
BMC Surg; 2021 Feb; 21(1):72. PubMed ID: 33536005
[TBL] [Abstract][Full Text] [Related]
31. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
[TBL] [Abstract][Full Text] [Related]
32. Inflammation scores predict the survival of patients with hepatocellular carcinoma who were treated with transarterial chemoembolization and recombinant human type-5 adenovirus H101.
He CB; Lin XJ
PLoS One; 2017; 12(3):e0174769. PubMed ID: 28355305
[TBL] [Abstract][Full Text] [Related]
33. Patients with early recurrence of hepatocellular carcinoma have poor prognosis.
Kobayashi T; Aikata H; Kobayashi T; Ohdan H; Arihiro K; Chayama K
Hepatobiliary Pancreat Dis Int; 2017 Jun; 16(3):279-288. PubMed ID: 28603096
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Nutritional Index (PNI) Predicts Tumor Recurrence of Very Early/Early Stage Hepatocellular Carcinoma After Surgical Resection.
Chan AW; Chan SL; Wong GL; Wong VW; Chong CC; Lai PB; Chan HL; To KF
Ann Surg Oncol; 2015 Dec; 22(13):4138-48. PubMed ID: 25801356
[TBL] [Abstract][Full Text] [Related]
35. Lymphocyte to monocyte ratio and prognostic nutritional index predict survival outcomes of hepatitis B virus-associated hepatocellular carcinoma patients after curative hepatectomy.
Wu SJ; Lin YX; Ye H; Li FY; Xiong XZ; Cheng NS
J Surg Oncol; 2016 Aug; 114(2):202-10. PubMed ID: 27199001
[TBL] [Abstract][Full Text] [Related]
36. Preoperative neutrophil to lymphocyte ratio and prognostic nutritional index predict overall survival after hepatectomy for hepatocellular carcinoma.
Okamura Y; Ashida R; Ito T; Sugiura T; Mori K; Uesaka K
World J Surg; 2015 Jun; 39(6):1501-9. PubMed ID: 25670038
[TBL] [Abstract][Full Text] [Related]
37. Significance of platelet count and platelet-based models for hepatocellular carcinoma recurrence.
Pang Q; Zhang JY; Xu XS; Song SD; Qu K; Chen W; Zhou YY; Miao RC; Liu SS; Dong YF; Liu C
World J Gastroenterol; 2015 May; 21(18):5607-21. PubMed ID: 25987786
[TBL] [Abstract][Full Text] [Related]
38. Expression of fibroblast growth factor 19 is associated with recurrence and poor prognosis of hepatocellular carcinoma.
Hyeon J; Ahn S; Lee JJ; Song DH; Park CK
Dig Dis Sci; 2013 Jul; 58(7):1916-22. PubMed ID: 23456506
[TBL] [Abstract][Full Text] [Related]
39. Prognostic value of γ-glutamyl transpeptidase to albumin ratio combined with aspartate aminotransferase to lymphocyte ratio in patients with hepatocellular carcinoma after hepatectomy.
Liu KJ; Lv YX; Niu YM; Bu Y
Medicine (Baltimore); 2020 Nov; 99(48):e23339. PubMed ID: 33235099
[TBL] [Abstract][Full Text] [Related]
40. Onodera's prognostic nutritional index is a strong prognostic indicator for patients with hepatocellular carcinoma after initial hepatectomy, especially patients with preserved liver function.
Tanemura A; Mizuno S; Hayasaki A; Gyoten K; Fujii T; Iizawa Y; Kato H; Murata Y; Kuriyama N; Kishiwada M; Sakurai H; Isaji S
BMC Surg; 2020 Oct; 20(1):261. PubMed ID: 33129309
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
